Literature DB >> 22398646

HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards.

N Sattar1, D Preiss.   

Abstract

This commentary aims to move the debate regarding the adoption of HbA(1c) for diagnosis of type 2 diabetes forwards by highlighting the need to avoid addressing irrelevant questions, in particular, comparison of individuals diagnosed with different diagnostic criteria. Instead, we provide a list of important future questions, including whether adoption of HbA(1c) as the primary diagnostic test improves uptake of diabetes screening, with resultant earlier diagnosis and improvement in outcomes.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22398646     DOI： 10.1007/s00125-012-2510-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


  17 in total

1.  Combined cardiovascular and diabetes risk assessment in primary care.

Authors:  D Preiss; K Khunti; N Sattar
Journal:  Diabet Med       Date:  2011-01       Impact factor: 4.359

2.  HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.

Authors:  Yoriko Heianza; Shigeko Hara; Yasuji Arase; Kazumi Saito; Kazuya Fujiwara; Hiroshi Tsuji; Satoru Kodama; Shiun Dong Hsieh; Yasumichi Mori; Hitoshi Shimano; Nobuhiro Yamada; Kinori Kosaka; Hirohito Sone
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

3.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

4.  Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

Authors:  Rebecca K Simmons; Stephen Sharp; S Matthijs Boekholdt; Lincoln A Sargeant; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  Arch Intern Med       Date:  2008-06-09

5.  Short-term variability in measures of glycemia and implications for the classification of diabetes.

Authors:  Elizabeth Selvin; Ciprian M Crainiceanu; Frederick L Brancati; Josef Coresh
Journal:  Arch Intern Med       Date:  2007-07-23

6.  The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women.

Authors:  S G Wannamethee; O Papacosta; P H Whincup; M C Thomas; C Carson; D A Lawlor; S Ebrahim; N Sattar
Journal:  Diabet Med       Date:  2011-01       Impact factor: 4.359

7.  Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.

Authors:  Kenji Shima; Keiko Chujo; Mayumi Yamada; Machiko Komatsu; Yoshihiko Noma; Takashi Mizuguchi
Journal:  Ann Clin Biochem       Date:  2011-12-22       Impact factor: 2.057

8.  Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes.

Authors:  Stephen Colagiuri; Crystal M Y Lee; Tien Y Wong; Beverley Balkau; Jonathan E Shaw; Knut Borch-Johnsen
Journal:  Diabetes Care       Date:  2010-10-26       Impact factor: 19.112

9.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.

Authors:  Simon J Griffin; Knut Borch-Johnsen; Melanie J Davies; Kamlesh Khunti; Guy E H M Rutten; Annelli Sandbæk; Stephen J Sharp; Rebecca K Simmons; Maureen van den Donk; Nicholas J Wareham; Torsten Lauritzen
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

10.  Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006.

Authors:  Catherine Kim; Kai McKeever Bullard; William H Herman; Gloria L Beckles
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152
View more
  6 in total

1.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

2.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

Review 3.  Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

Authors:  Leigh Perreault; Kristine Færch; Edward W Gregg
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

4.  Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Authors:  Leigh Perreault; Qing Pan; Emily B Schroeder; Rita R Kalyani; George A Bray; Samuel Dagogo-Jack; Neil H White; Ronald B Goldberg; Steven E Kahn; William C Knowler; Nestoras Mathioudakis; Dana Dabelea
Journal:  Diabetes Care       Date:  2019-07-18       Impact factor: 19.112

Review 5.  HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?

Authors:  Bernd Kowall; Wolfgang Rathmann
Journal:  Diabetes Metab Syndr Obes       Date:  2013-11-29       Impact factor: 3.168

6.  Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.

Authors:  Viveca Gyberg; Dirk De Bacquer; Kornelia Kotseva; Guy De Backer; Oliver Schnell; Jaakko Tuomilehto; David Wood; Lars Rydén
Journal:  BMJ Open       Date:  2016-12-08       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.